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Ca2þ homeostasis is an important factor, which is underlined
by the numerous clinical symptoms that involve Ca2þ
deficiencies. The overall Ca2þ balance is maintained by the
concerted action of Ca2þ absorption in the intestine,
reabsorption in the kidney, and exchange from bone, which
are all under the control of the calciotropic hormones that
are released upon a demand for Ca2þ . In the kidney, these
calciotropic hormones affect active Ca2þ reabsorption, which
consists of TRPV5 as the apical entry gate for Ca2þ influx,
calbindin-D28K as an intracellular ferry for Ca
2þ and, NCX1
and PMCA1b for extrusion of Ca2þ across the basolateral
membrane. This review highlights the action of hormones on
renal Ca2þ handling and focuses on the coordinated control
of the renal Ca2þ transport proteins. Parathyroid hormone
stimulates renal Ca2þ handling by regulating active Ca2þ
reabsorption on both the genomic and non-genomic level.
Estrogens harbor calciotropic hormone characteristics
positively regulating the expression of TRPV5, independently
of vitamin D. Besides having a strong regulatory effect on the
expression of the intestinal Ca2þ transport proteins, vitamin
D contributes to the overall Ca2þ balance by enhancing the
expression of the Ca2þ transport machinery in the kidney.
Dietary Ca2þ is involved in regulating its own handling by
controlling the expression of the renal Ca2þ transport
proteins. Thus, the magnitude of Ca2þ entry via TRPV5
controls the expression of the other Ca2þ transport proteins
underlining the gatekeeper function of this Ca2þ channel in
the renal Ca2þ handling.
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Ion homeostasis in our body is tightly regulated and
disturbances in its balance may lead to pathogenesis. The
kidney plays a vital role in this process by balancing the
dietary intake with the reabsorption from the pro-urine.
One of these ions is Ca2þ that plays a key role in many
physiological processes like hormone secretion, muscle
contraction, bone formation, nerve conduction, exocytosis,
and (in)activation of enzymes. The body, therefore, carefully
regulates the plasma concentration of Ca2þ within a narrow
range by the concerted action of intestinal Ca2þ absorption,
exchange of Ca2þ from bone and renal Ca2þ reabsorption.
An intrinsic physiological mechanism is sensing the Ca2þ
demand by a specialized Ca2þ -sensing receptor that activates
a cascade of pathways, eventually leading to the synthesis and
release of calciotropic hormones, including 1,25-dihydrox-
yvitamin D3 (1,25(OH)2D3), parathyroid hormone (PTH)
and calcitonin. These hormones act in a paracrine fashion,
efficiently regulating the above-described Ca2þ transport
processes. In the kidney, Ca2þ can re-enter the blood by
paracellular (passive) as well as transcellular (active) Ca2þ
reabsorption and the latter is the main target for the
calciotropic hormones. Active Ca2þ reabsorption comprises
a sequence of processes restricted to the distal convoluted
tubule (DCT) and the connecting tubule (CNT). At the
cellular level, Ca2þ enters the renal epithelial cell via the
highly Ca2þ -selective channel TRPV5 because of a steep
inward electrochemical gradient across the apical membrane.
In the cell, Ca2þ is bound to calbindin-D28K that ferries
Ca2þ from the apical side to the basolateral side where the
Naþ /Ca2þ -exchanger (NCX1) and the plasma membrane
ATPase (PMCA1b) extrude Ca2þ into the blood compart-
ment (Figure 1). In the intestine, a similar mechanism for
transcellular Ca2þ absorption occurs with TRPV6 as the
gatekeeper, calbindin-D9K as intracellular ferry of Ca
2þ and
PMCA1b as the extrusion mechanism. This review highlights
the hormonal regulation of Ca2þ reabsorption in the kidney
and focuses on the coordinated expression of the Ca2þ
transport proteins TRPV5, calbindin-D28K, NCX1, and
PMCA1b as the underlying mechanism contributing to the
Ca2þ balance.
RENAL Ca2þ HANDLING AND PTH
Primary hyperparathyroidism is characterized by PTH levels
that are inappropriate to the level of plasma Ca2þ and is one
of the endocrine disorders that underline the importance of
m i n i r e v i e w http://www.kidney-international.org
& 2006 International Society of Nephrology
Received 27 October 2005; revised 27 October 2005; accepted 7
November 2005; published online 11 January 2006
Correspondence: JGJ Hoendrop, Department of Physiology, Nijmegen
Centre for Molecular Life Sciences, Radboud University Nijmegen Medical
Centre, The Netherlands. E-mail: j.hoenderop@ncmls.ru.nl
650 Kidney International (2006) 69, 650–654
PTH in maintaining the Ca2þ balance. In addition,
mutations in the Ca2þ -sensing receptor, which couples the
plasma Ca2þ levels to the production and secretion of PTH
from the thyroid glands, were identified in patients with
familial hypocalciuric hypercalcemia, neonatal severe hyper-
parathyroidism (inactivating mutations),1 and autosomal-
dominant hypocalcemia (activating mutations).2 From the
clinical symptoms of these PTH-related disorders, including
hypo- or hypercalciuria and renal stone formation, it is
evident that renal Ca2þ handling is also affected. PTH
receptors have been detected throughout the nephron
including DCT and CNT, thus enabling the body to directly
control active Ca2þ reabsorption in the kidney via PTH.3 In
addition, genetic ablation of Ca2þ -sensing receptor resulted
in hyperparathyroidism and hypercalcemia, accompanied by
an upregulation of TRPV5 and TRPV6 in the kidney and
intestine, respectively (Table 1).4 To understand the mole-
cular regulation of the Ca2þ transport proteins by PTH,
parathyroidectomy was performed in rats.5 The effectiveness
of this treatment was evident from the marked reduction of
PTH levels and hyperphosphatemia, a well-known symptom
in hypoparathyroidism. Moreover, parathyroidectomy redu-
ced the expression of TRPV5, calbindin-D28K, and NCX1.
This decline in expression of the renal Ca2þ transport
proteins resulted in decreased active Ca2þ reabsorption and
the development of hypocalcemia. PTH supplementation in
these parathyroidectomized rats resulted in normalization of
the renal Ca2þ transport protein expression levels and
increased the plasma Ca2þ concentration.5 In addition, the
regulation by PTH was investigated in primary cultures of
rabbit CNT and cortical collecting duct (CCD) cells.5 PTH
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Ca2+
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Figure 1 | Transcellular Ca2þ reabsorption in the kidney.
Integrated model of active transcellular Ca2þ reabsorption in the
kidney that consists of TRPV5 as the apical entry gate for Ca2þ ,
calbindin-D28K as an intracellular ferry protein for Ca
2þ and, NCX1
and PMCA1b as Ca2þ extrusion systems across the basolateral
membrane to the blood compartment. See text for details.
Table 1 | Coordinated regulation of the Ca2+ transport proteins
Kidney Intestine
TRPV5 Calbindin-D28K NCX1 PMCA1b TRPV6 Calbindin-D9K PMCA1b Reference
PTH
CaSRa m NM NM NM m NM NM 4
Parathyroidectomy k k k = NM NM NM 5
Parathyroidectomy+PTH replacement therapy m m m = NM NM NM 5
PTH supplementation m m m m NM NM NM 5
Estrogens
Estrogen receptor-a/ k k k k k = = 3
Ovariectomy = = = = NM NM NM 3
Ovariectomy+replacement therapy m m/= m/= m/= m m/ = m/= 3
Estrogen supplementation in 1a-OHase/ m = = = m NM NM 3
Estrogen supplementation in ovariectomized VDR/ m = = = m = = 3
Vitamin D
Vitamin D deficiency k NM NM NM NM NM NM 3
1a-OHase/ k k k = NM NM NM 14/3
VDR/ k = = = k k = 15
1,25(OH)2D3 supplementation in vitamin D deficiency m m NM NM NM NM NM 3
Ca2+
Ca2+ supplementation in 1a-OHase/ m m m m NM NM NM 3
Miscellaneous
TRPV5/ ND k k = m m m 16
Overview of the different studies investigating the expression of the Ca2+ transport proteins in the kidney and intestine. Genetic ablation, dietary, and hormonal Ca2+
alterations demonstrated a concomitant regulation in expression of the renal and intestinal Ca2+ transport proteins.
m, upregulation; k, downregulation; =, no change in expression; NM, not measured; ND not detectable; PTH, parathyroid hormone; CaSR, Ca2+-sensing receptor; 1a-OHase,
25-hydroxyvitamin D3-1a-hydroxylase.
aGenetic ablation of the CaSR resulted in a severe hyperparathyroidism. See text for details.
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resulted in an elevated expression of the Ca2þ transport
proteins TRPV5, calbindin-D28K, NCX1, and PMCA1b in
these renal cultures. Taken together, these results indicate that
PTH stimulates renal Ca2þ handling by co-regulating the
expression of the Ca2þ transport proteins.
Regulation of expression of the Ca2þ transport proteins,
however, is a relatively slow process whereas a fast non-
genomic response operates on a time scale that is sufficient
for an immediate increase of Ca2þ reabsorption. An
established pathway for short-term PTH-stimulated active
Ca2þ reabsorption in the kidney is activation of adenylyl
cyclase, accumulation of cyclic adenosine 30,50 monopho-
sphate and subsequent stimulation of protein kinase A. PTH
addition to perfused rabbit CNT and primary cultures of
rabbit CNT and CCD resulted in a rise of cytosolic cyclic
adenosine 30,50 monophosphate levels accompanied by an
increase in the cytosolic Ca2þ concentration and trans-
cellular Ca2þ transport.6,7 Moreover, protein kinase A in-
hibitors reduced the PTH-mediated rise of cytosolic Ca2þ ,
which suggests that cyclic adenosine 30,50 monophosphate-
dependent phosphorylation is an essential step in short-term
PTH stimulation. In addition to cyclic adenosine 30,50 mono-
phosphate, a prominent role for protein kinase C was
demonstrated in the short-term PTH response.8 Thus,
besides a genomic effect, PTH can stimulate Ca2þ reabsorp-
tion directly via a short-term mechanism involving protein
kinase A and protein kinase C. Taken together, these studies
reveal that PTH-dependent stimulation of transcellular Ca2þ
reabsorption in the kidney occurs via both genomic and non-
genomic pathways.
RENAL Ca2þ HANDLING AND ESTROGENS
An increased risk for osteoporosis in postmenopausal
women is associated with estrogen deficiency. Furthermore,
estrogen deficiency is associated with renal Ca2þ wasting
and intestinal Ca2þ malabsorption that can be restored
by estrogen replacement therapy.9 From these findings, the
physiological relevance of estrogens in maintaining the Ca2þ
balance is feasible. In addition, this suggests that estrogens
can comply with the action of the calciotropic hormones,
regulating the expression of the renal Ca2þ transport
proteins. Estrogen receptors have been detected in DCT and
CNT, thus enabling the body to directly regulate active Ca2þ
reabsorption in the kidney by estrogen.3 Estrogen replace-
ment therapy in ovariectomized rats revealed an increase in
the expression of TRPV5, calbindin-D28K, NCX1, and
PMCA1b in the kidney suggesting an important role for this
hormone in regulating Ca2þ reabsorption.3 In addition,
genetic ablation of the estrogen receptor-a in mice decreased
the expression of the aforementioned renal Ca2þ transport
proteins. In principle, these effects could be explained by
estrogen-dependent vitamin D activation. This possibility
was investigated in vitamin D-deficient animal models.
Estrogen supplementation in 25-hydroxyvitamin D3-1a-
hydroxylase (1a-OHase) knockout mice increased the
expression of TRPV5 in the kidney, whereas the expression
of the other Ca2þ transport proteins remained unaltered.3 In
the intestine, estrogens regulate the expression of TRPV6 in
a vitamin D-independent manner, which became clear
from estrogen supplementation in vitamin D receptor and
1a-OHase knockout mice. This resulted in an upregulation of
duodenal TRPV6, whereas the expression of calbindin-D9K
and PMCA1b was not altered.3 Thus, estrogens harbor
calciotropic hormone characteristics regulating the expres-
sion of TRPV5 and TRPV6 in the kidney and intestine,
respectively.
RENAL Ca2þ HANDLING AND VITAMIN D
The active form of vitamin D, 1,25(OH)2D3, is an important
hormone in the body Ca2þ homeostasis. This is reflected by
several vitamin D-related disorders with symptoms like
rickets and hypercalciuria. Inactivating mutations in 1a-
OHase are associated with vitamin D-deficiency rickets type
110 and mutations in the vitamin D receptor are associated
with hypocalcemic rickets.11 Active Ca2þ reabsorption is a
main target for 1,25(OH)2D3, as illustrated by 1,25(OH)2D3-
stimulated Ca2þ transport in primary cultures of rabbit
CNT and CCD cells and human intestinal Caco-2 cells.6,12
Strikingly, microarray analysis of 1,25(OH)2D3-stimulated
carcinoma cells revealed TRPV6 as one of the most highly
vitamin D-responsive genes.13
Evidence for 1,25(OH)2D3-controlled expression of the
renal Ca2þ transport proteins came from rats that were
raised on a vitamin D-deficient diet. This diet decreased the
renal expression of TRPV5, which was accompanied by a
marked drop in plasma Ca2þ levels. In addition, genetic
ablation of 1a-OHase in mice resulted in severe hypocal-
cemia, hyperparathyroidism, bone abnormalities, and retar-
ded growth.14 In line with the development of hypocalcemia
is the diminished Ca2þ reabsorption in the kidney,
presumably as a result of the downregulated expression of
the Ca2þ transport proteins TRPV5, calbindin-D28K, and
NCX1.3 Supplementation of 1,25(OH)2D3 restored the
expression of the renal Ca2þ transport proteins and norma-
lized the hypocalcemia.3 Thus, vitamin D is of fundamental
importance for the regulation of renal Ca2þ transport
proteins and the maintenance of a normal Ca2þ balance.
Mice lacking TRPV5 display robust renal Ca2þ wasting
because of impaired Ca2þ reabsorption in the DCT and
CNT.15 In addition, elevated 1,25(OH)2D3 plasma levels,
intestinal Ca2þ hyperabsorption, and reduced bone thickness
were demonstrated. Besides the decreased storage of Ca2þ in
bone, compensatory hyperabsorption of Ca2þ in the
intestine prevented hypocalcemia in these knockout mice.
The underlying mechanism of this compensatory hyper-
absorption is hypervitaminosis D, which increases the
expression of the intestinal Ca2þ transport proteins TRPV6,
calbindin-D9K, and PMCA1b.
15 This finding indicates that a
renal Ca2þ leak because of the absence of TRPV5 triggers a
rescue mechanism resulting in an increased production of
vitamin D stimulating intestinal Ca2þ absorption. The
absence of hypervitaminosis D in the recently developed
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1a-OHase and TRPV5 double knockout (1a-OHase//
TRPV5/) mice, resulted in hypocalcemia and thus suggests
that the elevated level of 1,25(OH)2D3 in the TRPV5
/ mice
is responsible for the upregulation of intestinal Ca2þ
transport proteins and the resulting Ca2þ hyperabsorption.16
The absence of hyperabsorption in 1a-OHase//TRPV5/
mice generated in a more aggravated phenotype compared to
TRPV5 ablation. Thus, 1,25(OH)2D3 is crucial to compensate
for the renal Ca2þ leak and to maintain normal plasma Ca2þ
levels in TRPV5/ mice. Importantly, PTH levels in these
knockout models are comparable to wild-type littermates,
indicating that the observed regulation is not because of
altered PTH levels.
RENAL Ca2þ HANDLING AND DIETARY Ca2þ
Hereditary hypocalcemic vitamin D-resistant rickets, which
are caused by a genetic defect in the VDR gene, are treated
with a high dietary Ca2þ load.17 This suggests that dietary
Ca2þ can act as an additional regulatory mechanism of Ca2þ
handling independent of vitamin D. From a molecular point
of view, dietary Ca2þ affects the Ca2þ balance by regulating
the expression of the renal and intestinal Ca2þ transport
proteins. This is evident from high dietary Ca2þ supple-
mentation in mice which, among others, resulted in a
decreased TRPV5 and TRPV6 expression.3 This decline in
expression is likely mediated by the accompanied decrease in
1,25(OH)2D3 levels. However, in 1a-OHase knockout mice a
high dietary Ca2þ load normalized the plasma Ca2þ con-
centration as well as the expression of TRPV5, calbindin-
D28K, NCX1, and PMCA1b.
3 Likewise, in mice that lack
vitamin D receptor an increased dietary Ca2þ intake
upregulates the expression of TRPV5 in the kidney.17 In
addition, the expression of TRPV6 in the intestine was
increased. Taken together, dietary Ca2þ regulates the
expression of the Ca2þ transport proteins, independent of
1,25(OH)2D3.
COORDINATED CONTROL OF RENAL Ca2þ HANDLING
Various studies exploring the regulatory role of 1,25(OH)2D3,
estrogens, PTH, and dietary Ca2þ revealed a concomitant
regulation of the renal Ca2þ transport proteins. Additional
evidence for 1,25(OH)2D3- and PTH-independent regulation
of the Ca2þ balance was obtained from TRPV5 knockout
mice. Downregulation of the vitamin D-dependent Ca2þ
transport proteins calbindin-D28K and NCX1 in kidneys of
these knockout mice despite elevated levels of 1,25(OH)2D3
suggests that TRPV5 is primarily involved in the regulation
of the Ca2þ transport proteins expression in the kidney
independent of 1,25(OH)2D3. An interesting question is how
the expression of TRPV5 specifically coordinates the Ca2þ
transport machinery. Because TRPV5 is the gatekeeper
controlling the apical Ca2þ influx, it is feasible that the
magnitude of Ca2þ influx through TRPV5 determines the
expression of the Ca2þ transport proteins. This hypothesis
was recently investigated using primary cultures of rabbit
CNT and CCD.5 Long-term exposure to PTH stimulated
transepithelial Ca2þ transport in these epithelial cells, and
concomitantly elevated the expression of TRPV5, calbindin-
D28K, and NCX1. Blockage of TRPV5 channel activity by
ruthenium red eliminated PTH-stimulated transepithelial
Ca2þ transport, which was accompanied by a reduction in
NCX1 and calbindin-D28K expression. These findings support
the hypothesis that the magnitude of the Ca2þ influx
through TRPV5 controls the expression of the Ca2þ
transport proteins. This implicates an efficient regulation of
Ca2þ reabsorption in the kidney where Ca2þ regulates its
own transport activity. An important question that remains
to be answered is how the flux of Ca2þ through TRPV5
adjusts the expression of the Ca2þ transport proteins.
Previous studies have indicated that Ca2þ is important for
gene transcription. A Ca2þ -responsive element has been
identified in the promoter sequence of calbindin-D28K that
partly underlies the Purkinje cell-specific expression of
calbindin-D28K.
18 However, it is not known whether this
element is active in the kidney and/or additional intracellular
signaling molecules are involved. An established pathway
for Ca2þ -dependent signaling to the nucleus is via the
ubiquitously expressed Ca2þ sensor calmodulin that can
stimulate gene expression via distinct pathways. Nuclear
calmodulin-dependent kinase IV and the transcription factor
CREB (cyclic adenosine 30,50 monophosphate response
binding protein) are among the calmodulin-regulated
proteins that affect gene expression.19 Besides calmodulin,
the Ca2þ -binding protein calcineurin/nuclear factor of
activated T cells signaling pathway can also stimulate gene
expression upon a rise of intracellular Ca2þ and recently this
pathway has been shown to be essential for the expression of
the sodium-phosphate co-transporter (NaPi) in the kidney.
20
Currently, it is not known whether these pathways are
involved in renal TRPV5-mediated Ca2þ signaling.
To further identify gene products in the kidney that are
regulated by high dietary Ca2þ and/or 1,25(OH)2D3, cDNA
microarray analysis was performed on kidneys from high
dietary Ca2þ or 1,25(OH)2D3-treated 1a-OHase knockout
mice. In this study, 1,25(OH)2D3 induced a significant
regulation of B1000 genes, whereas dietary Ca2þ supple-
mentation of the 1a-OHase knockout mice revealed B2000
controlled genes.3 Importantly, Ca2þ transport proteins
including NCX1 and calbindin-D28K were among the dietary
Ca2þ regulated genes. This confirms previous findings that
besides vitamin D, dietary Ca2þ regulates the expression of
the renal Ca2þ transport proteins. Furthermore, intracellular
signaling molecules, including calmodulin, were identified
that might be part of the signaling pathway that underlie the
Ca2þ regulated expression in the kidney. Further research is,
however, needed to establish a comprehensive molecular
mechanism underlying the Ca2þ -dependent genomic regu-
lation of the renal Ca2þ transport proteins.
CONCLUSION
Regulation of the renal Ca2þ transport proteins TRPV5,
calbindin-D28K, NCX1, and PMCA1b, which determine the
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net active flux of Ca2þ to the blood compartment, is of
physiological importance to maintain the Ca2þ balance. We
have presented an overview of the current knowledge
concerning the hormonal regulation of renal Ca2þ handling
and focused on the mechanism of coordinated control of the
renal Ca2þ transport proteins. These findings constitute the
mechanism of regulating active Ca2þ reabsorption in the
kidney via TRPV5. Once the activity of the gatekeeper
TRPV5 is altered, the complete Ca2þ transport machinery
will be affected accordingly, as the magnitude of the Ca2þ
flux that enters the cell via TRPV5 coordinates the expression
of the other Ca2þ transport proteins. The underlying
molecular signaling pathway, however, remains to be identi-
fied. Future studies like promoter analysis in the Ca2þ
transporter genes to identify Ca2þ -responsive elements, and
experiments focusing on the different Ca2þ -dependent
signaling pathways will bring further knowledge about the
Ca2þ -regulated coordinated control of renal Ca2þ transpor-
ters. From a clinical point of view, these findings reveal an
efficient way to regulate overall renal Ca2þ handling by
compounds that specifically stimulate or inhibit the gate-
keeper TRPV5.
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